Renal impairment and all-cause mortality in cardiovascular disease: effect modification by type 2 diabetes mellitus

被引:11
作者
Selvarajah, Sharmini [1 ,2 ,3 ]
Uiterwaal, Cuno S. P. M. [2 ]
Haniff, Jamaiyah [1 ]
van der Graaf, Yolanda [2 ]
Visseren, Frank L. J. [4 ]
Bots, Michiel L. [2 ]
机构
[1] Kuala Lumpur Hosp, Minist Hlth Malaysia, Clin Res Ctr, Kuala Lumpur 50586, Malaysia
[2] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands
[3] Univ Malaya, Dept Social & Prevent Med, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia
[4] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands
关键词
Cardiovascular disease; diabetes mellitus; mortality; renal impairment; GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; FACTOR INTERVENTION TRIAL; RISK-FACTOR; GENERAL-POPULATION; INDEPENDENT PREDICTORS; MYOCARDIAL-INFARCTION; 2ND MANIFESTATIONS; FOLLOW-UP; ALBUMINURIA;
D O I
10.1111/eci.12035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Renal impairment and type 2 diabetes mellitus (DM) are well-known independent risk factors for mortality. The evidence of their combined effects on mortality is unclear, but of importance because it may determine aggressiveness of treatment. This study sought to assess and quantify the effect modification of diabetes on renal impairment in its association with mortality. Materials and methods Patients with cardiovascular disease or at high risk, recruited in the Second Manifestations of ARTerial disease cohort study, were selected. A total of 7135 patients were enrolled with 33 198 person-years of follow-up. Renal impairment was defined by albuminuria status and estimated glomerular filtration rate (eGFR). Outcome was all-cause mortality. Results Mortality increased progressively with each stage of renal impairment, for both albuminuria status and eGFR, for diabetics and non-diabetics. There was no effect modification by diabetes on mortality risk due to renal impairment. The relative excess risk due to interaction (RERI) for DM and microalbuminuria was 0.21 (-0.11, 0.52), for overt proteinuria -1.12 (-2.83, 0.59) and for end-stage renal failure (ESRF) 0.32 (-3.65, 4.29). The RERI for DM with eGFR of 6089 mL/min/1.73 m2 was -0.31(-0.92, 0.32), for eGFR of 3059 mL/min/1.73 m2 -0.07 (-0.76, 0.62) and for eGFR of < 30 mL/min/1.73 m2 0.38 (-0.85, 1.61). Conclusions Type 2 diabetes mellitus does not modify nor increase the risk relation between all-cause mortality and renal impairment. These findings suggest that the hallmark for survival is the prevention and delay in progression of renal impairment in patients with cardiovascular disease.
引用
收藏
页码:198 / 207
页数:10
相关论文
共 39 条
[1]   Interaction: A word with two meanings creates confusion [J].
Ahlbom, A ;
Alfredsson, L .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2005, 20 (07) :563-564
[2]   The independent and combined risk of diabetes and non-endstage renal impairment in non-ST-segment elevation acute coronary syndromes [J].
Ahmed, Shaheeda ;
Cannon, Christopher P. ;
Giugliano, Robert P. ;
Murphy, Sabina A. ;
Morrow, David A. ;
Antman, Elliott M. ;
Braunwald, Eugene ;
Gibson, C. Michael .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2008, 131 (01) :105-112
[3]   Calculating measures of biological interaction [J].
Andersson, T ;
Alfredsson, L ;
Källberg, H ;
Zdravkovic, S ;
Ahlbom, A .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2005, 20 (07) :575-579
[4]   Relation of baseline presence and severity of renal disease to long-term mortality in persons with known stroke [J].
Ani, Chinbam ;
Ovbiagele, Bruce .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 288 (1-2) :123-128
[5]   Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study [J].
Bruno, G ;
Merletti, F ;
Biggeri, A ;
Bargero, G ;
Ferrero, S ;
Pagano, G ;
Cavallo-Perin, P .
DIABETOLOGIA, 2005, 48 (03) :427-434
[6]  
Cirillo M, 2010, J NEPHROL, V23, P125
[7]   Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [J].
Drury, P. L. ;
Ting, R. ;
Zannino, D. ;
Ehnholm, C. ;
Flack, J. ;
Whiting, M. ;
Fassett, R. ;
Ansquer, J. -C. ;
Dixon, P. ;
Davis, T. M. E. ;
Pardy, C. ;
Colman, P. ;
Keech, A. .
DIABETOLOGIA, 2011, 54 (01) :32-43
[8]   Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality - The Multiple Risk Factor Intervention Trial experience [J].
Eberly, LE ;
Cohen, JD ;
Prineas, R ;
Yang, LF .
DIABETES CARE, 2003, 26 (03) :848-854
[9]   Chronic kidney disease definition and classification: no need for a rush to judgment [J].
Eknoyan, Garabed .
KIDNEY INTERNATIONAL, 2009, 75 (10) :1015-1018
[10]   Albuminuria and renal insufficiency prevalence guides population screening: Results from the NHANES III [J].
Garg, AX ;
Kiberd, BA ;
Clark, WF ;
Haynes, RB ;
Clase, CM .
KIDNEY INTERNATIONAL, 2002, 61 (06) :2165-2175